Companion Animals

Companion Dog Canine Arthritis Solensia

The monoclonal antibody treatment Solensia for feline arthritis pain, bringing new welfare options for cats.

Key Facts

Lokivetmab (Solensia) is a monoclonal antibody targeting nerve growth factor in cats
Monthly injection provides sustained pain relief for osteoarthritis in cats
Clinical trials show significant improvement in mobility and quality of life
The treatment avoids the gastrointestinal and renal risks associated with long-term NSAID use
Owners report obvious behavioral improvements including increased play and grooming

Welfare Considerations

Solensia represents a transformative welfare advance for cats with osteoarthritis pain. The monthly injection eliminates daily compliance issues and avoids the organ toxicity risks of long-term NSAIDs. Many previously undertreated cats are now receiving effective analgesia for the first time.

What You Can Do

Ask your vet about Solensia if your cat shows signs of reduced mobility or arthritis pain
Assess your cat's mobility using the Feline Musculoskeletal Pain Index
Advocate for arthritis pain screening as a routine part of senior cat wellness examinations